Automatically Tracking and Detecting Significant Nodal Mass Shrinkage During Head-and-Neck Radiation Treatment Using Image Saliency

Author(s):  
Yu-chi Hu ◽  
Cynthia Polvorosa ◽  
Chiaojung Jillian Tsai ◽  
Margie Hunt
2020 ◽  
Vol 5 (4) ◽  
pp. 1021-1025
Author(s):  
Liza Blumenfeld ◽  
Lisa Evangelista ◽  
Maggie Kuhn ◽  
Kristen Linnemeyer ◽  
Nogah Nativ-Zeltzer ◽  
...  

The COVID-19 pandemic has created challenges in providing health care throughout the United States. Despite limitations in in-person clinical care aimed at reducing transmission risk and preserving personal protective equipment, patients with head and neck cancer continue to undergo radiation-based treatment, resulting in the need for adapted care pathways. Speech-language pathologists play an instrumental role in the care of patients undergoing head and neck radiation prior to, during, and following the conclusion of treatment. To address the ad hoc need for guidance on speech-language pathologists management of patients with head and neck cancer during the pandemic, the California Head and Neck Consortium constructed recommendations for best practices before, during, and after chemoradiation therapy, based on the combined experience of several academic medical centers. These guidelines aim to provide a model that maintains high quality of care while minimizing risk of viral exposure to patients and clinicians.


2010 ◽  
Vol 55 (21) ◽  
pp. 6491-6500 ◽  
Author(s):  
Adil Al-Mayah ◽  
Joanne Moseley ◽  
Shannon Hunter ◽  
Mike Velec ◽  
Lily Chau ◽  
...  

2020 ◽  
Vol 163 (6) ◽  
pp. 1109-1113
Author(s):  
Karuna Dewan ◽  
Chloe Santa Maria ◽  
Julia Noel

Objective There is little consensus regarding the efficacy and safety of treatment options for cricopharyngeal (CP) achalasia. The purpose of this scoping review is to assess the literature regarding the various treatments for this disease. Data Sources PubMed was searched for all articles addressing treatment of adult CP achalasia between January 1990 and June 2019. Review Methods In total, 351 peer-reviewed results were reviewed by 3 otolaryngologists for inclusion. After review of titles, abstracts, and full texts, 60 articles were selected. Results Among included studies, 55% were retrospective and 45% were prospective. Forty-five percent of studies were case series. CP achalasia etiologies included idiopathic (28%), cerebrovascular accident (CVA) (28%), neurologic disease (17%), head and neck radiation treatment (11%), Zenker’s diverticulum (10%), and myositis (5%). Most commonly employed treatments were botulinum toxin injection (40%), endoscopic CP myotomy (30%), dilation with either balloon or bougie (25%), and open CP myotomy (15%). A proportion of patients were treated with more than 1 approach. Most studies included both subjective and objective outcome measures. Complications were reported most often in patients with a history of head and neck radiation. Conclusions Small sample sizes and heterogeneity of causes and treatments of CP achalasia, as well as short duration of follow-up, make it challenging to assess the superiority of one treatment over another. There is a need for a prospective study that more directly compares outcomes of administration of botulinum toxin, dilation, and CP myotomy in patients with CP achalasia of similar etiologies.


2010 ◽  
Author(s):  
Adil Al-Mayah ◽  
Joanne Moseley ◽  
Shannon Hunter ◽  
Mike Velec ◽  
Lily Chau ◽  
...  

2020 ◽  
Vol 5 (1) ◽  
pp. 1-15
Author(s):  
Doha Abdel Gawad ◽  
Manal Fareed ◽  
Naser Abd El- Bary ◽  
Hanan Attallah

Sign in / Sign up

Export Citation Format

Share Document